Trident Limited has announced the resignation of Mr. Rahul Roongta from his position as Group Chief Financial Officer, effective from the closing hours of January 02, 2026. The company disclosed this development under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Resignation Details

Mr. Rahul Roongta, who served as the Group Chief Financial Officer and Senior Management Personnel, tendered his resignation citing personal reasons. The resignation was formally submitted on December 26, 2025, and became effective on January 02, 2026.

Regulatory Compliance

The company has fulfilled all mandatory disclosure requirements as per SEBI regulations. The announcement was made in compliance with Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.

Transition Process

In his resignation letter addressed to Group CEO Shri Samir Joshipura, Mr. Roongta expressed gratitude to the Senior Management, Board of Directors, and fellow team members for their support and guidance during his tenure. He requested completion of relieving formalities by January 02, 2026, which the company has accommodated.

Corporate Communication

The disclosure was signed by Company Secretary Sushil Sharma (ICSI Membership No. F6535) and communicated to both the National Stock Exchange of India Limited and BSE Limited. The company has provided verification mechanisms for stakeholders to authenticate the authority of signatories through their official website.

This leadership transition represents a significant change in Trident Limited's senior management structure, with the company ensuring full regulatory compliance throughout the process.

Trident Lifeline has announced the acquisition of an additional 9.04% stake in Trident Mediquip, marking a significant strategic investment in the medical equipment sector. The transaction was completed for approximately ₹44.20 million, reflecting the company's commitment to expanding its healthcare portfolio.

Transaction Details

The acquisition represents a substantial investment by Trident Lifeline in strengthening its position within the medical equipment industry. The following table outlines the key parameters of this transaction:

Strategic Implications

This acquisition demonstrates Trident Lifeline's strategic focus on consolidating its presence in the healthcare and medical equipment sector. The investment in Trident Mediquip aligns with the company's broader objectives of expanding its operational capabilities and market reach within the medical industry.

The transaction value of ₹44.20 million indicates the company's willingness to make substantial investments to strengthen its portfolio companies. This move could potentially enhance Trident Lifeline's competitive position in the medical equipment market.

Market Position

With this additional stake acquisition, Trident Lifeline continues to build its investment portfolio in the healthcare sector. The company's decision to increase its holding in Trident Mediquip suggests confidence in the medical equipment company's growth prospects and operational performance.

The investment reflects Trident Lifeline's strategic approach to portfolio management and its focus on sectors with strong growth potential. This acquisition may provide the company with enhanced influence over Trident Mediquip's strategic direction and operational decisions.